Brainstorm Cell Therapeutics (BCLI)

3.93 -0.05 (1.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/16/18 *Est.)

Latest Headlines

Form S-3/A BRAINSTORM CELL THERAPEU September 21, 2018 5:33 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Announces New U.S. Patent for Industrial Scale Manufacturing of NurOwn September 13, 2018 7:32 AM - StreetInsider BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn® September 13, 2018 7:30 AM - Globe NewsWire BrainStorm to Present at FDA and Scientific Workshops Highlighting Innovation in ALS Trial Designs and Continued Progress with NurOwn® Cellular Therapy Platform September 12, 2018 8:49 AM - Globe NewsWire BrainStorm Cell Therapeutics Announces New Presentation Time at the H.C. Wainwright & Co. 20th Annual Investor Conference September 5, 2018 11:35 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Aug 28 Filed by: Araya Arturo September 4, 2018 5:03 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Appoints Arturo Araya as CCO September 4, 2018 8:05 AM - StreetInsider BrainStorm Appoints Arturo Araya as Chief Commercial Officer September 4, 2018 8:01 AM - Globe NewsWire BrainStorm Cell Therapeutics to Provide Corporate Update at the H.C. Wainwright & Co 20th Annual Investor Conference August 29, 2018 8:00 AM - Globe NewsWire Brainstorm Cell Therapeutics (BCLI) Reports Successful Interim Safety Analysis in Phase 3 Trial of NurOwn Therapy for ALS August 23, 2018 8:21 AM - StreetInsider BrainStorm Cell Therapeutics Announces Successful Interim Safety Analysis in Phase 3 Trial of NurOwn® Therapy for ALS August 23, 2018 8:20 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Jul 26 Filed by: Lebovits Chaim July 27, 2018 4:06 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Announces Grant of New European Patent for NurOwn July 25, 2018 9:07 AM - StreetInsider BrainStorm Announces Grant of a New European Patent for NurOwn® July 25, 2018 9:06 AM - PR NewsWire Brainstorm Cell Therapeutics (BCLI) Reports Q2 Loss of $0.16/Share July 23, 2018 8:06 AM - StreetInsider Form 10-Q BRAINSTORM CELL THERAPEU For: Jun 30 July 23, 2018 8:03 AM - SEC Filing BrainStorm Announces Financial Results for the Second Quarter of 2018 and Provides a Corporate Update July 23, 2018 8:00 AM - PR NewsWire BrainStorm to Announce Second Quarter Financial Results of 2018 and Provide a Corporate Update on Monday July 23 July 17, 2018 8:32 AM - PR NewsWire BrainStorm Granted Japanese Patent for NurOwn® July 5, 2018 7:30 AM - PR NewsWire BrainStorm Announces Second U.S. Manufacturing Site for NurOwn® Production July 2, 2018 7:41 AM - PR NewsWire Form EFFECT BRAINSTORM CELL THERAPEU July 2, 2018 6:02 AM - SEC Filing Form S-3 BRAINSTORM CELL THERAPEU June 29, 2018 4:08 PM - SEC Filing BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello June 28, 2018 5:00 AM - PR NewsWire BrainStorm Provides Update on "Right to Try" Policy June 26, 2018 8:05 AM - PR NewsWire Brainstorm Cell Therapeutics (BCLI) will not provide ALS therapy under U.S. Right to Try act - Reuters June 26, 2018 7:31 AM - StreetInsider Brainstorm Cell Therapeutics (BCLI) to Host Conference Call to Announce Its "Right To Try" Policy June 25, 2018 9:47 AM - StreetInsider BrainStorm to Host Tomorrow a Conference Call to Announce Its "Right To Try" Policy June 25, 2018 9:46 AM - PR NewsWire Full Article List